about
MLK3 Signaling in Cancer InvasionNHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.Novel systemic therapy against malignant pleural mesothelioma.Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathwayMolecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling.The Biological Function of the Prion Protein: A Cell Surface Scaffold of Signaling ModulesScaffolding during the cell cycle by A-kinase anchoring proteins.Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.15α-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.The Emerging Role of TRAF7 in Tumor Development.Malignant Mesothelioma: Time to Translate?Looking for the needle in the haystack: Proteome-based identification of treatment targets in NF2-related nervous system tumors.Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cellsEssential signaling in NF2 loss-related tumours: the therapeutic potential of CRL4DCAF1 and mTOR combined inhibition.Upstream paths for Hippo signaling in Drosophila organ development.Reduced RAC1 activity inhibits cell proliferation and induces apoptosis in neurofibromatosis type 2(NF2)-associated schwannoma.Single cell polarity in liquid phase facilitates tumour metastasis.L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis.Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.Phenotype-driven identification of epithelial signalling clusters.Haploid genetic screens identify genetic vulnerabilities to microtubule-targeting agents.Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers.Muscle action potential scans and ultrasound imaging in neurofibromatosis type 2.Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.[Hereditary tumor syndromes in neuropathology].Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
P2860
Q26746892-46669619-8ADC-4519-80F6-3135CA414702Q27316840-9E44F7C9-8BFE-40A7-84A3-1C6F8904EBF9Q33890499-29FCBF21-A7FA-4517-8956-03F26147A948Q34479368-BAAF9CE5-2D6C-4C1E-8D7D-4CF7B2A59C26Q37330688-B29EBE15-3CBA-4949-A43F-2AF575EFBD2EQ37599488-3F0339EE-3CF2-4AA0-945D-A63C28DF17E6Q37710410-3392F7AE-8E23-48EC-9332-409704D84D77Q38552469-8235B1A3-B027-43BA-B717-99B5C30A6ABBQ38697736-83AAC976-864F-49E3-9D20-B24B55621E0CQ38722193-FF71F9CA-49F8-4D2B-9A2D-02FACC3D939DQ38972707-0F7FDAC9-F045-45A2-8F99-ADB3A4811120Q38997320-A27C9601-DBCD-4996-B4D4-BBCF1B225FBEQ39366003-3A66CD36-4C79-4664-BD76-E8F2A9A1169AQ42197352-F31E3303-0007-422C-9C42-834103F872B6Q42223215-206B6F29-6F3F-4F58-800A-7B52DBAAE19EQ47138523-8DA3346B-9B90-44FC-B04D-3FEC071F42FDQ49346894-BED30E7B-0EDF-46F7-9F0C-000C972278F7Q49959424-4908AE47-51A2-4F7E-854E-653EF74D9DD9Q50868185-6871A3C8-4EC8-47B9-AC95-752800C7A9D8Q52593254-4D7C155A-3CEA-42EC-BEB9-2A9768657547Q52642770-482E7229-D0CB-4F8B-A6F7-28C314A7132BQ52673177-5566E166-21CD-49A8-AE1F-BC8E02CE9A8EQ52717015-AE23FCDC-AB7F-4822-BDCD-1DB296E970EAQ52726723-22F9BFDB-B37C-47B8-A262-0BB180B42B57Q53065702-77F8B30B-67FE-402C-A9A4-5BC3690F37B7Q53075204-81EE908C-574B-4278-9772-1C7AA4456625Q53312284-821997C6-06A0-4ED9-AF4E-DE9643D79AFBQ55234046-1E19FF68-FE23-45AA-87BB-7C13FE6CACEBQ55355075-00F0C1F6-281E-4598-B06D-1B19576835BBQ55383186-624B4F6B-AF14-4029-B315-6C51D8DC9E96Q57306913-C3E0FF1A-AC9D-44D4-83AA-C05D8F00EFE2
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Role of Merlin/NF2 inactivation in tumor biology.
@ast
Role of Merlin/NF2 inactivation in tumor biology.
@en
type
label
Role of Merlin/NF2 inactivation in tumor biology.
@ast
Role of Merlin/NF2 inactivation in tumor biology.
@en
prefLabel
Role of Merlin/NF2 inactivation in tumor biology.
@ast
Role of Merlin/NF2 inactivation in tumor biology.
@en
P2860
P921
P356
P1433
P1476
Role of Merlin/NF2 inactivation in tumor biology.
@en
P2093
A M Petrilli
C Fernández-Valle
P2860
P2888
P304
P356
10.1038/ONC.2015.125
P407
P577
2015-04-20T00:00:00Z
2016-02-04T00:00:00Z